PT - JOURNAL ARTICLE AU - Hoyle, Brian ED - Zarbin, Marco TI - Ranibizumab 0.5 mg Safe and Effective for Treatment of DME DP - 2014 01 TA - MD Conference Express PG - 8--9 VI - 14 IP - 43 4099 - http://mdc.sagepub.com/content/14/43/8.short 4100 - http://mdc.sagepub.com/content/14/43/8.full AB - This article discusses a post hoc analysis of 5 studies of the humanized monoclonal antibody ranibizumab directed against vascular endothelial growth factor-A in the treatment of diabetic macular edema. The analysis focuses on the arterial thromboembolic events associated with ranibizumab that have been reported in controlled clinical trials.